Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Authors: Barbieri M, Rizzo MR, Fava I, Sardu C, Angelico N, Paolisso P, Abbatecola AM, Paolisso G, Marfella R
Date: 2016
Scope of interest: metabolism, diabetes
Authors: Violi F et al
Date: Sep 2022
Scope of interest: infectious disease
Authors: Landi F, Pistelli R, Abbatecola AM, Barillaro C, Brandi V, Lattanzio F
Date: 2011
Scope of interest: pharmacology, respiratory diseases
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide